Cargando…
Pimecrolimus Is a Potent Inhibitor of Allergic Reactions to Hymenopteran Venom Extracts and Birch Pollen Allergen In Vitro
Pimecrolimus (Elidel, SDZ ASM 981) is an anti-inflammatory and immunomodulatory 33-epichloro-derivative of macrolactam ascomycin, with low potential for affecting systemic immune responses compared with other calcineurin inhibitors, cyclosporin A and tacrolimus. Despite numerous studies focused on t...
Autores principales: | Heneberg, Petr, Riegerová, Kamila, Kučera, Petr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643035/ https://www.ncbi.nlm.nih.gov/pubmed/26562153 http://dx.doi.org/10.1371/journal.pone.0142953 |
Ejemplares similares
-
The Major Birch Pollen Allergen Bet v 1 Induces Different Responses in Dendritic Cells of Birch Pollen Allergic and Healthy Individuals
por: Smole, Ursula, et al.
Publicado: (2015) -
89 Is Basophil Specific Response to Hymenoptera Venom Related to T Regulatory Cells?
por: Kucera, Petr, et al.
Publicado: (2012) -
Real‐world benefits of allergen immunotherapy for birch pollen‐associated allergic rhinitis and asthma
por: Wahn, Ulrich, et al.
Publicado: (2018) -
First evaluation of a symbiotic food supplement in an allergen exposure chamber in birch pollen allergic patients
por: Bergmann, Karl-Christian, et al.
Publicado: (2020) -
Relevant Patient Benefit of Sublingual Immunotherapy with Birch Pollen Allergen Extract in Allergic Rhinitis: An Open, Prospective, Non-Interventional Study
por: Blome, Christine, et al.
Publicado: (2020)